ueec_8k.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report: July 19, 2013
(Date of earliest event reported: July 18, 2013)
 
UNITED HEALTH PRODUCTS, INC.
(Exact name of registrant as specified in its charter)

Nevada
 
814-00717
 
84-1517723
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)

c/o Morse & Morse, PLLC
1400 Old Country Road, Suite 302
Westbury, NY 11590
 (Address of principal executive offices, zip code)

(516) 487-1452
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))
 


 
 

 
 
Item 7.01.  Regulation FD Disclosure

On July 18, 2013, the Company issued a press release, a copy of which is appended hereto.

Item 9.01.  Financial Statements and Exhibits.
 
Exhibit   Description
     
99.1   Press release dated July 18, 2013. (Filed herewith.)
 
 
2

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
UNITED HEALTH PRODUCTS, INC.  
 
 
 
 
Dated: July 22, 2013
By:
/s/ Dr. Phillip Forman
 
 
 
Dr. Phillip Forman
 
 
 
Chief Executive Officer
 
 
 
 
 
3